Medicare carve-out for brain-injury hospitals could raise costs for all beneficiaries

What it does

This bill creates a new Medicare payment category for specialized long-term care hospitals that treat spinal cord and brain injuries. Hospitals meeting strict criteria—treating at least 80% spinal cord/brain injury patients, maintaining research programs, and drawing 30% of patients from out-of-state—can opt out of standard Medicare payment formulas and receive payments negotiated directly with the government instead, potentially allowing higher reimbursement rates.

Why we flagged it

The bill creates a narrow exemption from standard Medicare payment rules for a specific class of long-term care hospitals, allowing them to negotiate higher reimbursement rates outside the normal DRG system. This is functionally a payment carve-out for a defined subset of providers.

What the text implies

• The 80% patient-composition threshold and 175-discharge minimums per condition per year effectively limit designation to a very small number of hospitals, creating a de facto monopoly or duopoly in catastrophic neurorehabilitation care in some regions.
• By exempting designated hospitals from the Prospective Payment System (PPS) and LTCH-PPS, the bill removes the cost-containment mechanism that normally constrains Medicare reimbursement, potentially allowing unlimited rate growth for these providers.

The full analysis lists 5 implications of this text.

Who stands to gain

Long-term care hospitals specializing in spinal cord and brain injury rehabilitation; Neurorehabilitation-focused health systems and academic medical centers; Medical device manufacturers (Resmed, Boston Scientific) serving rehabilitation markets